Literature DB >> 5777215

Tricyclic antidepressants: evidence for an intraneuronal site of action.

W D Reid, F J Stefano, S Kurzepa, B B Brodie.   

Abstract

Desipramine, a tricyclic antidepressant drug, almost completely prevents the accumulation of tritiated norepinephrine by sympathetic neurons of the rat heart after the injection of a tracer dose of the labeled amine. However, desipramine does not alter the accumulation of norepinephrine after the injection of a large dose of the neurohormone. Despite the failure of desipramine to block the neuronal uptake of norepinephrine, it still prevents exogenous norepinephrine from displacing the endogenous neurohormone (previously labeled with H(3)-norepinephrine) from intraneuronal storage sites.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5777215     DOI: 10.1126/science.164.3878.437

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  4 in total

1.  Desipramine and some other antidepressant drugs decrease the major norepinephrine metabolite 3,4-dihydroxyphenylglycol-sulphate in the rat brain.

Authors:  M Nielsen; C Braestrup
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

2.  A reappraisal of the interaction between tricyclic antidepressants and reserpine-like drugs.

Authors:  P Willner; D Clark
Journal:  Psychopharmacology (Berl)       Date:  1978-06-15       Impact factor: 4.530

3.  A possible intraneuronal site of action of thymoleptics.

Authors:  T Okada; Y Seki; I Kuruma
Journal:  Psychopharmacology (Berl)       Date:  1979-05-08       Impact factor: 4.530

4.  Protriptyline induced inhibition of the in vivo 3H-noradrenaline synthesis from 3H-L-dopa in the rat brain.

Authors:  M Nielsen; L Eplov; J Scheel-Krüger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.